Transarterial chemoembolization (TACE) Clinical Trials
3 recruitingProcedure
Phase 23Phase 31Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
Hepatocellular Carcinoma (HCC)
Tuen Mun Hospital106 enrolled1 locationNCT07293468
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled4 locationsNCT07239245
Recruiting
Phase 1Phase 2
Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma (HCC)
Yoon Jun Kim24 enrolled1 locationNCT06911255